HYPERTENSION (HTN) IN PATIENTS (PTS) TREATED WITH IBRUTINIB (IBR) FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Authors :: Isaac Deonarine
M. Sarraf Yazdy
Colleen Dorsey
Bruce D. Cheson
Hannah Morse
Joseph R. Carver
Anthony R. Mato
Lindsey E. Roeker
Mayur Narkhede
Kristen E. Battiato
Kaitlin Kennard
Julie Goodfriend
L. Gashonia
Joanna Rhodes
Stephen J. Schuster
Source :: Hematological Oncology. 37:212-213
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Chronic lymphocytic leukemia
Hematology
General Medicine
medicine.disease
chemistry.chemical_compound
chemistry
Internal medicine
Ibrutinib
Medicine
In patient
business

Full Text Access

Tools